Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.

Conclusions: Compared with other serum biomarkers, AFU showed a better prognostic value for long-term survival in patients with early stage ESCC. PMID: 31656672 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31656672?dopt=Abstract

Source: Journal of Thoracic Disease - October 30, 2019 Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research